Ireland· IE-PA-PA1986/110/001
Antabuse 400 mg Effervescent Tablets
A disulfiram product containing disulfiram, registered in Ireland by Teva B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Disulfiram is registered in 13 of 19 countries.
Countries holding a registration under ATC N07BB01 (disulfiram), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Disulfiram · ATC N07BB01
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of disulfiram costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.19 in Spain to $0.55 in Switzerland — a ×2.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Disulfiram · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.55
- ES Spain$0.19
The record
At a glance
HPRA (Ireland)- Active substance
- Disulfiram
- Manufacturer
- Teva B.V.
- Country
- Ireland (IE)
- ATC code
- N07BB01
- ATC class
- Disulfiram
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1986/110/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
210 interactions on record for disulfiram.
Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Disulfiram · interactions on record
210 records
- 19 severe
- 163 moderate
- 15 minor
- 13 info
Most severe, free to view
- EthanolB05XX04severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- MetronidazoleJ01XD01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Disulfiram in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAntabus 400 mg BrustablettMedartuum AB
- CzechiaANTABUSActavis Group PTC ehf., Hafnarfjördur
- SwitzerlandAntabus Dispergetten
- IcelandAntabusTeva B.V.*
- United KingdomAntabuse 200mg tabletsActavis UK Ltd
- United StatesDisulfiramSigmapharm Laboratories, LLC
- NorwayAntabus
- NetherlandsAntabus dispergetten 400 mg, bruistablettenAurobindo Pharma B.V.
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Czechia · Antabus
- Germany · Tetraethylthiuramdisulfid Smartpractice Europe
- Denmark · Antabus
- Spain · Antabus
- Finland · Antabus
- France · Esperal
- United Kingdom (Northern Ireland) · Antabuse, Disulfiram Accord-Uk
- Hungary · Antaethyl
- Iceland · Antabus
- Italy · Antabuse Dispergettes, Etiltox
- Malta · Disural
- Netherlands · Disulfiram Aurobindo, Refusal
- Norway · Antabus
- Poland · Anticol, Disulfiram Wzf
- Portugal · Tetradin
- Romania · Antalcol
- Sweden · Antabus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d8c24ecf-c842-4c1a-b56d-f41e98dc1a15 GET /v1/drugs/d8c24ecf-c842-4c1a-b56d-f41e98dc1a15?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Effervescent tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N07BB",
"N07BB01"
],
"strength": null,
"pa_number": "PA1986/110/001",
"substances": [
"Disulfiram"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "06/02/1985",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about disulfiram.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.